LAMB2 and neoplasm: Zhang et al. designed dual-responsive laminin mimic peptide (LMMP)-based nanosubmarines with both pH-responsive His6 sequence, tumor microthrombus-targeting peptide CREKA and fibril-forming sequence KLVFF, and the intravenously injected nanoparticles were enriched to the tumor site by CREKA.